![Michael Koeris](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Koeris
Fondatore presso Corvium, Inc.
Posizioni attive di Michael Koeris
Società | Posizione | Inizio | Fine |
---|---|---|---|
Corvium, Inc.
![]() Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | Direttore/Membro del Consiglio | - | - |
Fondatore | 01/03/2009 | - | |
Amministratore Delegato | 22/08/2016 | - | |
Direttore operativo | 02/06/2011 | 22/08/2016 | |
Corporate Officer/Principal | - | - | |
Presidente | 02/06/2011 | 02/05/2013 | |
Xeno Biosciences, Inc.
![]() Xeno Biosciences, Inc. BiotechnologyHealth Technology Xeno Biosciences, Inc. operates as a biopharmaceutical company. It offers XEN-101, an oral formulation that shifts the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. The company was founded by Hasan Celiker and is headquartered in Somerville, MA. | Direttore/Membro del Consiglio | - | - |
Vulcan Biologics, Inc.
![]() Vulcan Biologics, Inc. BiotechnologyHealth Technology Vulcan Biologics, Inc. is a company that focuses on next-generation microbiome modulation. Vulcan Biologics is based in Irvine, CA and was founded by Michael Koeris, who has been the CEO since incorporation. The company aims to precisely and stably modulate any arbitrary microbiome, which is key to any commercial and clinical success. The company is building a broad platform to modulate any microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiomes. | Presidente | 29/10/2019 | - |
Fondatore | 29/10/2019 | - | |
Segretario Aziendale | 29/10/2019 | - | |
Treasurer | 29/10/2019 | - | |
Amministratore Delegato | 29/10/2019 | - |
Storia della carriera di Michael Koeris
Precedenti posizioni note di Michael Koeris
Società | Posizione | Inizio | Fine |
---|---|---|---|
McKinsey GmbH & Co. KG
![]() McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany. | Corporate Officer/Principal | - | - |
KPMG Consulting, Inc. | Corporate Officer/Principal | - | - |
Formazione di Michael Koeris
Freie Universität Berlin | Graduate Degree |
Boston University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Germania | 3 |
Posizioni
Chief Executive Officer | 3 |
Founder | 3 |
Corporate Officer/Principal | 3 |
Settori
Consumer Services | 3 |
Commercial Services | 3 |
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Corvium, Inc.
![]() Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | Technology Services |
KPMG Consulting, Inc. | Commercial Services |
McKinsey GmbH & Co. KG
![]() McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany. | Commercial Services |
Xeno Biosciences, Inc.
![]() Xeno Biosciences, Inc. BiotechnologyHealth Technology Xeno Biosciences, Inc. operates as a biopharmaceutical company. It offers XEN-101, an oral formulation that shifts the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. The company was founded by Hasan Celiker and is headquartered in Somerville, MA. | Health Technology |
Vulcan Biologics, Inc.
![]() Vulcan Biologics, Inc. BiotechnologyHealth Technology Vulcan Biologics, Inc. is a company that focuses on next-generation microbiome modulation. Vulcan Biologics is based in Irvine, CA and was founded by Michael Koeris, who has been the CEO since incorporation. The company aims to precisely and stably modulate any arbitrary microbiome, which is key to any commercial and clinical success. The company is building a broad platform to modulate any microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiomes. | Health Technology |
- Borsa valori
- Insiders
- Michael Koeris
- Esperienza